Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapid-response vaccines--does DNA offer a solution?

Gareth M Forde1

  • 1Victorian Endowment for Science, Knowledge, and Innovation (VESKI), Department of Chemical Engineering, Monash University, Clayton, Melbourne, Australia, 3800. gareth.forde@eng.monash.edu.au

Nature Biotechnology
|September 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N,N'-Carbonyldiimidazole-mediated functionalization of superparamagnetic nanoparticles as vaccine carrier.

Colloids and surfaces. B, Biointerfaces·2010
Same author

Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2010
Same author

Microparticle-mediated gene delivery for the enhanced expression of a 19-kDa fragment of merozoite surface protein 1 of Plasmodium falciparum.

Biotechnology progress·2009
Same author

Versatility of polymethacrylate monoliths for chromatographic purification of biomolecules.

Journal of separation science·2009
Same author

Preparation, analysis and use of an affinity adsorbent for the purification of GST fusion protein.

Methods in molecular biology (Clifton, N.J.)·2008
Same author

Plasmid DNA purification via the use of a dual affinity protein.

Methods in molecular biology (Clifton, N.J.)·2008
Same journal

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Nature biotechnology·2026
Same journal

Unlocking the chemical potential of filamentous fungi using prime editing.

Nature biotechnology·2026
Same journal

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026
Same journal

Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

Nature biotechnology·2026
Same journal

A retargeted recombinase for precise insertion of large DNA.

Nature biotechnology·2026
See all related articles

Plasmid DNA vaccines offer a solution for future infectious disease outbreaks, overcoming limitations in traditional vaccine production methods for faster responses.

Area of Science:

  • Vaccinology
  • Molecular Biology
  • Infectious Disease Preparedness

Background:

  • Conventional vaccine production faces challenges in speed and scalability, hindering rapid responses to emerging infectious threats.
  • Influenza pandemics and novel infectious agents require agile and efficient vaccine development platforms.

Purpose of the Study:

  • To highlight the advantages of plasmid DNA as a vaccine platform for pandemic preparedness.
  • To demonstrate how plasmid DNA technology addresses limitations in traditional vaccine manufacturing.

Main Methods:

  • Review of existing literature on plasmid DNA vaccine technology.
  • Comparative analysis of plasmid DNA versus conventional vaccine production.

Main Results:

Related Experiment Videos

  • Plasmid DNA vaccines bypass many conventional manufacturing bottlenecks.
  • This platform allows for rapid adaptation to new or mutated infectious agents.

Conclusions:

  • Plasmid DNA technology represents a significant advancement for responding to future pandemics.
  • Adoption of this approach can enhance global health security against infectious diseases.